NEOCHEM — Neochem Bio Solutions Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual income statement for Neochem Bio Solutions, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final
Revenue
Total Revenue	482	611	842	1,107
Cost of Revenue
Gross Profit	153	210	272	343
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	452	564	724	927
Operating Profit	30.1	47.7	118	180
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	15.2	26.7	103	172
Provision for Income Taxes
Net Income After Taxes	10.7	18	77.5	120
Net Income Before Extraordinary Items
Net Income	10.7	18	77.5	120
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10.7	18	77.5	120
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.856	1.43	6.14	9.02